schliessen

Filtern

 

Bibliotheken

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0

These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessme... Full description

Journal Title: European journal of nuclear medicine and molecular imaging 2019, Vol.46 (3), p.540-557
Main Author: Law, Ian
Other Authors: Albert, Nathalie L , Arbizu, Javier , Boellaard, Ronald , ezga, Alexander , Galldiks, Norbert , la Fougere, Christian , Langen, Karl-Josef , Lopci, Egesta , Lowe, Val , McConathy, Jonathan , Quick, Harald H , Sattler, Bernhard , Schuster, David M , Tonn, Joerg-Christian , Weller, Michael
Format: Electronic Article Electronic Article
Language: English
Subjects:
FDG
FET
MET
PET
Publisher: Berlin/Heidelberg: Springer Berlin Heidelberg
ID: ISSN: 1619-7070
Link: https://www.ncbi.nlm.nih.gov/pubmed/30519867
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6351513
title: Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
format: Article
creator:
  • Law, Ian
  • Albert, Nathalie L
  • Arbizu, Javier
  • Boellaard, Ronald
  • ezga, Alexander
  • Galldiks, Norbert
  • la Fougere, Christian
  • Langen, Karl-Josef
  • Lopci, Egesta
  • Lowe, Val
  • McConathy, Jonathan
  • Quick, Harald H
  • Sattler, Bernhard
  • Schuster, David M
  • Tonn, Joerg-Christian
  • Weller, Michael
subjects:
  • Adult
  • Amino Acids
  • ards
  • Assisted
  • atira
  • ATTENUATION CORRECTION
  • Brain
  • BRAIN-TUMORS
  • C-11-METHIONINE PET
  • Cardiology
  • CENTRAL-NERVOUS-SYSTEM
  • Child
  • Computer
  • diagnostic imaging
  • Diagnostic systems
  • EANM PROCEDURE GUIDELINES
  • Emission Tomography
  • F-18-FET PET
  • FDG
  • FDOPA
  • FET
  • Fluorodeoxyglucose F18
  • Glioma
  • Glioma - diagnostic imaging
  • Guidelines
  • HIGH-GRADE
  • Humans
  • Image Processing
  • Image Processing, Computer-Assisted
  • Imaging
  • Isotope Labeling
  • Journal Article
  • Magnetic resonance imaging
  • Medical
  • Medical imaging
  • Medicine
  • Medicine & Public Health
  • MET
  • Neuroimaging
  • Nuclear Medicine
  • O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET
  • Oncology
  • Orthopedics
  • Patients
  • PET
  • Positron
  • Positron emission
  • Positron-Emission Tomography - standards
  • POSITRON-EMISSION-TOMOGRAPHY
  • Practice Guidelines as Topic
  • pubmedpublicationtype
  • pure
  • Quality Control
  • Radiology
  • Radiology Nuclear Medicine
  • Recurrence
  • RECURRENT MALIGNANT GLIOMA
  • Reference St
  • Reference Standards
  • Research Design
  • researchoutput
  • Societies
  • Societies, Medical
  • Standards
  • Tomography
  • Working groups
ispartof: European journal of nuclear medicine and molecular imaging, 2019, Vol.46 (3), p.540-557
description: These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations.
language: eng
source:
identifier: ISSN: 1619-7070
fulltext: no_fulltext
issn:
  • 1619-7070
  • 1619-7089
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.827073
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_pubme
recordidTN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6351513
sourceformatXML
sourcesystemPC
sourcerecordid2150236298
originalsourceidFETCH-LOGICAL-1744t-9069de11422b5002b9a24a1fce6b303a0ef68f61feb2e7824a14873f1c1d8b190
addsrcrecordideNqFUktv1DAYjBCIlsIP4IIsceGSrl-xYw5IVdmWoj4QlFOFLMePrausvdhJK34M_xWHLQvtoVycxzcz-jwzVfUSwV0EIZ9lCHEjaojammLIa_Go2kYMiZrDVjzevHO4VT3L-QoWIG7F02qLwAaJlvHt6ufH6MMA5nunJ7NynM0-lwOsktKD1xYsRm9s74PNsy-nJydHZRK1NWOyIA8qGJVMBi4m4Jdq4cMCRAcWvY9LlcGYpx-f5ufgxg-XICnjY6862_fWALX0IQKlfeEXHXBxUKP228H7w7fg2qbsYwBoFz6vnjjVZ_vi9rlTfT2Yn-9_qI_PDo_2945rxCkdagGZMBYhinHXFE86oTBVyGnLOgKJgtax1jHkbIctb6cZbTlxSCPTdkjAnerdWnc1dktrtA1DUr1cpXKt9ENG5eXdSfCXchGvJSMNahApAkdrgbiyQflk73BNsIOMRmLeIAm5YEoZwrgWprGGCt6hBnfQMm1aZorW6f-0TIlgJW-cLJFKbRDn2DQGI-qgMRhjyiwxCAtGCJ-We3N7uxS_jzYPcumzLjmoYOOYJUZcYCw45QX6-h70Ko4pFO8LqoGYMCzagkJrlE4x52TdZkME5dRMuW6mLIWTUzPlZPGrfy3eMP5UsQD4PVHtBzWUJhTHff-gNF4zcxENC5v-Lv0Q6WJNCippnzf7pHFxm3cxfvoI_ZR97_XvXbLkzHFFWiitUkJS7bQUmDiJGVW0NYTQkuUvIEYdIg
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid2150236298
display
typearticle
titleJoint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
creatorLaw, Ian ; Albert, Nathalie L ; Arbizu, Javier ; Boellaard, Ronald ; ezga, Alexander ; Galldiks, Norbert ; la Fougere, Christian ; Langen, Karl-Josef ; Lopci, Egesta ; Lowe, Val ; McConathy, Jonathan ; Quick, Harald H ; Sattler, Bernhard ; Schuster, David M ; Tonn, Joerg-Christian ; Weller, Michael
creatorcontribLaw, Ian ; Albert, Nathalie L ; Arbizu, Javier ; Boellaard, Ronald ; ezga, Alexander ; Galldiks, Norbert ; la Fougere, Christian ; Langen, Karl-Josef ; Lopci, Egesta ; Lowe, Val ; McConathy, Jonathan ; Quick, Harald H ; Sattler, Bernhard ; Schuster, David M ; Tonn, Joerg-Christian ; Weller, Michael
descriptionThese joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations.
identifier
0ISSN: 1619-7070
1EISSN: 1619-7089
2DOI: 10.1007/s00259-018-4207-9
3PMID: 30519867
languageeng
publisherBerlin/Heidelberg: Springer Berlin Heidelberg
subjectAdult ; Amino Acids ; ards ; Assisted ; atira ; ATTENUATION CORRECTION ; Brain ; BRAIN-TUMORS ; C-11-METHIONINE PET ; Cardiology ; CENTRAL-NERVOUS-SYSTEM ; Child ; Computer ; diagnostic imaging ; Diagnostic systems ; EANM PROCEDURE GUIDELINES ; Emission Tomography ; F-18-FET PET ; FDG ; FDOPA ; FET ; Fluorodeoxyglucose F18 ; Glioma ; Glioma - diagnostic imaging ; Guidelines ; HIGH-GRADE ; Humans ; Image Processing ; Image Processing, Computer-Assisted ; Imaging ; Isotope Labeling ; Journal Article ; Magnetic resonance imaging ; Medical ; Medical imaging ; Medicine ; Medicine & Public Health ; MET ; Neuroimaging ; Nuclear Medicine ; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET ; Oncology ; Orthopedics ; Patients ; PET ; Positron ; Positron emission ; Positron-Emission Tomography - standards ; POSITRON-EMISSION-TOMOGRAPHY ; Practice Guidelines as Topic ; pubmedpublicationtype ; pure ; Quality Control ; Radiology ; Radiology Nuclear Medicine ; Recurrence ; RECURRENT MALIGNANT GLIOMA ; Reference St ; Reference Standards ; Research Design ; researchoutput ; Societies ; Societies, Medical ; Standards ; Tomography ; Working groups
ispartofEuropean journal of nuclear medicine and molecular imaging, 2019, Vol.46 (3), p.540-557
rights
0info:eu-repo/semantics/openAccess
1The Author(s) 2018
2European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-1744t-9069de11422b5002b9a24a1fce6b303a0ef68f61feb2e7824a14873f1c1d8b190
citesFETCH-LOGICAL-1744t-9069de11422b5002b9a24a1fce6b303a0ef68f61feb2e7824a14873f1c1d8b190
orcidid0000-0001-9644-7496
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30519867$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Law, Ian
1Albert, Nathalie L
2Arbizu, Javier
3Boellaard, Ronald
4ezga, Alexander
5Galldiks, Norbert
6la Fougere, Christian
7Langen, Karl-Josef
8Lopci, Egesta
9Lowe, Val
10McConathy, Jonathan
11Quick, Harald H
12Sattler, Bernhard
13Schuster, David M
14Tonn, Joerg-Christian
15Weller, Michael
title
0Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
1European journal of nuclear medicine and molecular imaging
addtitle
0Eur J Nucl Med Mol Imaging
1Eur J Nucl Med Mol Imaging
descriptionThese joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations.
subject
0Adult
1Amino Acids
2ards
3Assisted
4atira
5ATTENUATION CORRECTION
6Brain
7BRAIN-TUMORS
8C-11-METHIONINE PET
9Cardiology
10CENTRAL-NERVOUS-SYSTEM
11Child
12Computer
13diagnostic imaging
14Diagnostic systems
15EANM PROCEDURE GUIDELINES
16Emission Tomography
17F-18-FET PET
18FDG
19FDOPA
20FET
21Fluorodeoxyglucose F18
22Glioma
23Glioma - diagnostic imaging
24Guidelines
25HIGH-GRADE
26Humans
27Image Processing
28Image Processing, Computer-Assisted
29Imaging
30Isotope Labeling
31Journal Article
32Magnetic resonance imaging
33Medical
34Medical imaging
35Medicine
36Medicine & Public Health
37MET
38Neuroimaging
39Nuclear Medicine
40O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET
41Oncology
42Orthopedics
43Patients
44PET
45Positron
46Positron emission
47Positron-Emission Tomography - standards
48POSITRON-EMISSION-TOMOGRAPHY
49Practice Guidelines as Topic
50pubmedpublicationtype
51pure
52Quality Control
53Radiology
54Radiology Nuclear Medicine
55Recurrence
56RECURRENT MALIGNANT GLIOMA
57Reference St
58Reference Standards
59Research Design
60researchoutput
61Societies
62Societies, Medical
63Standards
64Tomography
65Working groups
issn
01619-7070
11619-7089
fulltextfalse
rsrctypearticle
creationdate2019
recordtypearticle
recordideNqFUktv1DAYjBCIlsIP4IIsceGSrl-xYw5IVdmWoj4QlFOFLMePrausvdhJK34M_xWHLQvtoVycxzcz-jwzVfUSwV0EIZ9lCHEjaojammLIa_Go2kYMiZrDVjzevHO4VT3L-QoWIG7F02qLwAaJlvHt6ufH6MMA5nunJ7NynM0-lwOsktKD1xYsRm9s74PNsy-nJydHZRK1NWOyIA8qGJVMBi4m4Jdq4cMCRAcWvY9LlcGYpx-f5ufgxg-XICnjY6862_fWALX0IQKlfeEXHXBxUKP228H7w7fg2qbsYwBoFz6vnjjVZ_vi9rlTfT2Yn-9_qI_PDo_2945rxCkdagGZMBYhinHXFE86oTBVyGnLOgKJgtax1jHkbIctb6cZbTlxSCPTdkjAnerdWnc1dktrtA1DUr1cpXKt9ENG5eXdSfCXchGvJSMNahApAkdrgbiyQflk73BNsIOMRmLeIAm5YEoZwrgWprGGCt6hBnfQMm1aZorW6f-0TIlgJW-cLJFKbRDn2DQGI-qgMRhjyiwxCAtGCJ-We3N7uxS_jzYPcumzLjmoYOOYJUZcYCw45QX6-h70Ko4pFO8LqoGYMCzagkJrlE4x52TdZkME5dRMuW6mLIWTUzPlZPGrfy3eMP5UsQD4PVHtBzWUJhTHff-gNF4zcxENC5v-Lv0Q6WJNCippnzf7pHFxm3cxfvoI_ZR97_XvXbLkzHFFWiitUkJS7bQUmDiJGVW0NYTQkuUvIEYdIg
startdate201903
enddate201903
creator
0Law, Ian
1Albert, Nathalie L
2Arbizu, Javier
3Boellaard, Ronald
4ezga, Alexander
5Galldiks, Norbert
6la Fougere, Christian
7Langen, Karl-Josef
8Lopci, Egesta
9Lowe, Val
10McConathy, Jonathan
11Quick, Harald H
12Sattler, Bernhard
13Schuster, David M
14Tonn, Joerg-Christian
15Weller, Michael
general
0Springer Berlin Heidelberg
1Springer Nature B.V
2Springer-Verl
scope
05DI
15DJ
2AGBBJ
3QVL
4CGR
5CUY
6CVF
7ECM
8EIF
9NPM
10AAYXX
11CITATION
123V.
137RV
147TK
157X7
167XB
1788E
188AO
198FE
208FG
218FH
228FI
238FJ
248FK
25ABUWG
26ARAPS
27AZQEC
28BBNVY
29BENPR
30BGLVJ
31BHPHI
32DWQXO
33FYUFA
34GHDGH
35GNUQQ
36HCIFZ
37K9.
38KB0
39LK8
40M0S
41M1P
42M7P
43NAPCQ
44P5Z
45P62
46PQEST
47PQQKQ
48PQUKI
49PRINS
507X8
51BOBZL
52CLFQK
535PM
orcididhttps://orcid.org/0000-0001-9644-7496
sort
creationdate201903
titleJoint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
authorLaw, Ian ; Albert, Nathalie L ; Arbizu, Javier ; Boellaard, Ronald ; ezga, Alexander ; Galldiks, Norbert ; la Fougere, Christian ; Langen, Karl-Josef ; Lopci, Egesta ; Lowe, Val ; McConathy, Jonathan ; Quick, Harald H ; Sattler, Bernhard ; Schuster, David M ; Tonn, Joerg-Christian ; Weller, Michael
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1744t-9069de11422b5002b9a24a1fce6b303a0ef68f61feb2e7824a14873f1c1d8b190
rsrctypearticles
prefilterarticles
languageeng
creationdate2019
topic
0Adult
1Amino Acids
2ards
3Assisted
4atira
5ATTENUATION CORRECTION
6Brain
7BRAIN-TUMORS
8C-11-METHIONINE PET
9Cardiology
10CENTRAL-NERVOUS-SYSTEM
11Child
12Computer
13diagnostic imaging
14Diagnostic systems
15EANM PROCEDURE GUIDELINES
16Emission Tomography
17F-18-FET PET
18FDG
19FDOPA
20FET
21Fluorodeoxyglucose F18
22Glioma
23Glioma - diagnostic imaging
24Guidelines
25HIGH-GRADE
26Humans
27Image Processing
28Image Processing, Computer-Assisted
29Imaging
30Isotope Labeling
31Journal Article
32Magnetic resonance imaging
33Medical
34Medical imaging
35Medicine
36Medicine & Public Health
37MET
38Neuroimaging
39Nuclear Medicine
40O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET
41Oncology
42Orthopedics
43Patients
44PET
45Positron
46Positron emission
47Positron-Emission Tomography - standards
48POSITRON-EMISSION-TOMOGRAPHY
49Practice Guidelines as Topic
50pubmedpublicationtype
51pure
52Quality Control
53Radiology
54Radiology Nuclear Medicine
55Recurrence
56RECURRENT MALIGNANT GLIOMA
57Reference St
58Reference Standards
59Research Design
60researchoutput
61Societies
62Societies, Medical
63Standards
64Tomography
65Working groups
toplevelpeer_reviewed
creatorcontrib
0Law, Ian
1Albert, Nathalie L
2Arbizu, Javier
3Boellaard, Ronald
4ezga, Alexander
5Galldiks, Norbert
6la Fougere, Christian
7Langen, Karl-Josef
8Lopci, Egesta
9Lowe, Val
10McConathy, Jonathan
11Quick, Harald H
12Sattler, Bernhard
13Schuster, David M
14Tonn, Joerg-Christian
15Weller, Michael
collection
0NARCIS
1NARCIS: Datasets
2Narcis: Open Access
3NARCIS:Publications
4Medline
5MEDLINE
6MEDLINE (Ovid)
7MEDLINE
8MEDLINE
9PubMed
10CrossRef
11ProQuest Central (Corporate)
12Nursing & Allied Health Database
13Neurosciences Abstracts
14Health & Medical Collection
15ProQuest Central (purchase pre-March 2016)
16Medical Database (Alumni Edition)
17ProQuest Pharma Collection
18ProQuest SciTech Collection
19ProQuest Technology Collection
20ProQuest Natural Science Collection
21Hospital Premium Collection
22Hospital Premium Collection (Alumni Edition)
23ProQuest Central (Alumni) (purchase pre-March 2016)
24ProQuest Central (Alumni Edition)
25Advanced Technologies & Aerospace Collection
26ProQuest Central Essentials
27Biological Science Collection
28ProQuest Central
29Technology Collection
30Natural Science Collection
31ProQuest Central Korea
32Health Research Premium Collection
33Health Research Premium Collection (Alumni)
34ProQuest Central Student
35SciTech Premium Collection
36ProQuest Health & Medical Complete (Alumni)
37Nursing & Allied Health Database (Alumni Edition)
38ProQuest Biological Science Collection
39Health & Medical Collection (Alumni Edition)
40Medical Database
41Biological Science Database
42Nursing & Allied Health Premium
43Advanced Technologies & Aerospace Database
44ProQuest Advanced Technologies & Aerospace Collection
45ProQuest One Academic Eastern Edition
46ProQuest One Academic
47ProQuest One Academic UKI Edition
48ProQuest Central China
49MEDLINE - Academic
50OpenAIRE (Open Access)
51OpenAIRE
52PubMed Central (Full Participant titles)
jtitleEuropean journal of nuclear medicine and molecular imaging
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0Law, Ian
1Albert, Nathalie L
2Arbizu, Javier
3Boellaard, Ronald
4ezga, Alexander
5Galldiks, Norbert
6la Fougere, Christian
7Langen, Karl-Josef
8Lopci, Egesta
9Lowe, Val
10McConathy, Jonathan
11Quick, Harald H
12Sattler, Bernhard
13Schuster, David M
14Tonn, Joerg-Christian
15Weller, Michael
formatjournal
genrearticle
ristypeJOUR
atitleJoint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
jtitleEuropean journal of nuclear medicine and molecular imaging
stitleEur J Nucl Med Mol Imaging
addtitleEur J Nucl Med Mol Imaging
date2019-03
risdate2019
volume46
issue3
spage540
epage557
pages540-557
issn1619-7070
eissn1619-7089
abstractThese joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations.
copBerlin/Heidelberg
pubSpringer Berlin Heidelberg
pmid30519867
doi10.1007/s00259-018-4207-9
orcididhttps://orcid.org/0000-0001-9644-7496
oafree_for_read